BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14581433)

  • 1. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
    Castro M
    J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Managing methotrexate toxicity: a case report].
    Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
    Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
    de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
    Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
    [No Abstract]   [Full Text] [Related]  

  • 4. "Rescue" agent may circumvent rare but deadly complication from chemotherapy.
    Jenks S
    J Natl Cancer Inst; 1997 Jun; 89(12):840-1. PubMed ID: 9196247
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
    Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the literature.
    Brandes JC; Grossman SA; Ahmad H
    Cancer Invest; 2006; 24(3):283-7. PubMed ID: 16809156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
    van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R; Rentsch K; Di Paolo E; Popovic MB
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management recommendations in patients with methotrexate intoxication].
    Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
    Nakagawa K; Yamazaki K; Kunitoh H; Hida T; Gemba K; Shinkai T; Ichinose Y; Adachi S; Nambu Y; Saijo N; Fukuoka M
    Jpn J Clin Oncol; 2008 May; 38(5):339-46. PubMed ID: 18434338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
    Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M
    Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update of pemetrexed in thoracic oncology].
    Brechot JM; Morère JF
    Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 16. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis.
    Ahmad S; Shen FH; Bleyer WA
    Arch Intern Med; 1978 Jul; 138(7):1146-7. PubMed ID: 666479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation recall dermatitis with pemetrexed.
    Hureaux J; Le Guen Y; Tuchais C; Savary L; Urban T
    Lung Cancer; 2005 Nov; 50(2):255-8. PubMed ID: 16111784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-induced status epilepticus.
    Naing A; Luong D; Extermann M
    Am J Hematol; 2005 Sep; 80(1):35-7. PubMed ID: 16138356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pemetrexed: from preclinic to clinic].
    Lansiaux A; Lokiec F
    Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.